The new products include pre-roll and flower, and also includes the Double Chocolate Brownie. Via its wholly-owned subsidiary Valens Labs Ltd, the firm also has Canada s only ISO17025 accredited analytical services lab
The Valens Company Inc (TSE:VLNS) (OTCQX:VLNCF) (FRA:7LV) said it has increased its total addressable market in Canada with the launch of a host of new products in partnership with Verse Cannabis under the Verse Originals and Verse Concentrates lines.
The new products include pre-roll and flower (at the request of the company s customer base), and also includes the Double Chocolate Brownie – one of the first confectionery products of its type to hit the Canadian recreational market, said Valens.
Valens applies for Nasdaq listing in the US
The company plans to ask its shareholders to approve a consolidation at its annual and special meeting next month The Valens Company is a British Columbia-based producer of cannabis products, medical and recreational
The Valens Company Inc (TSE:VLNS) (OTCQX:VLNCF) (FRA:7LV), a producer of cannabis products, announced that it has submitted an initial application to list its common shares on the Nasdaq. We have taken a significant step forward in achieving one of our main goals for 2021 by filing our initial application for listing on the Nasdaq on the back of announcing our first acquisition in the US, President Jeff Fallows said in a statement. We believe that listing in the US will unlock various opportunities to enhance corporate visibility, increase liquidity and broaden overall awareness of The Valens Company to a larger investor base while driving value for our shareholders.
Valens to buy US CBD product producer Green Roads in US$40M cash and stock deal
The move provides Valens with immediate entry into the US market with a leading CBD health and wellness brand that has an established manufacturing and distribution platform Green Roads, based in south Florida, is the largest privately owned CBD company in the US
The Valens Company Inc (TSX:VLNS) (OTCQX:VLNCF) said it has reached a definitive agreement to acquire CBD company Green Roads and its majority-owned manufacturing subsidiary in a cash and share transaction worth US$40 million, plus up to US$20 million more in milestone payments.